in a double-blind , placebo-controlled study the encephalotropic effects of dup 996 , a novel phenylindolinone derivative for alzheimer 's disease enhancing the release of acetylcholine in cholinergic nerve terminals in the brain only when its release is triggered , were studied with special consideration of the pharmacodynamic time-course .
C0006104
brain
C0518609
studied